LIC MF Healthcare Fund Direct Growth

Fund Overview

Fund Size

₹103 Cr

Expense Ratio

1.42%

ISIN

INF397L01LK4

Minimum SIP

₹500

Exit Load

1.00%

Inception Date

28 Feb 2019

About this fund

LIC MF Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by LIC Mutual Fund. This fund has been in existence for 7 years, 6 months and 27 days, having been launched on 28-Feb-19.
As of 23-Sep-26, it has a Net Asset Value (NAV) of ₹38.25, Assets Under Management (AUM) of 103.11 Crores, and an expense ratio of 1.42%.

LIC MF Healthcare Fund Direct Growth has given a CAGR return of 19.40% since inception.
The fund's asset allocation comprises around 98.52% in equities, 0.00% in debts, and 1.48% in cash & cash equivalents.
You can start investing in LIC MF Healthcare Fund Direct Growth with a SIP of ₹500 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+18.09%

+16.88% (Cat Avg.)

3 Years

+23.99%

+21.85% (Cat Avg.)

5 Years

+12.96%

+14.34% (Cat Avg.)

Since Inception

+19.40%

— (Cat Avg.)

Portfolio Summaryas of 31st August 2026

Equity	₹101.58 Cr	98.52%
Others	₹1.53 Cr	1.48%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹10.41 Cr	10.09%
Divi's Laboratories Ltd	Equity	₹9.58 Cr	9.29%
Torrent Pharmaceuticals Ltd	Equity	₹6.65 Cr	6.45%
Neuland Laboratories Ltd	Equity	₹6.58 Cr	6.38%
Apollo Hospitals Enterprise Ltd	Equity	₹6.42 Cr	6.23%
Navin Fluorine International Ltd	Equity	₹5.83 Cr	5.65%
Aurobindo Pharma Ltd	Equity	₹5.33 Cr	5.17%
Aster DM Quality Care Ltd Ordinary Shares	Equity	₹4.97 Cr	4.82%
Zydus Lifesciences Ltd	Equity	₹4.94 Cr	4.79%
Gland Pharma Ltd	Equity	₹4.05 Cr	3.93%
Fortis Healthcare Ltd	Equity	₹3.9 Cr	3.78%
Global Health Ltd	Equity	₹3.29 Cr	3.19%
Ipca Laboratories Ltd	Equity	₹3.28 Cr	3.18%
Metropolis Healthcare Ltd	Equity	₹3.27 Cr	3.17%
Cohance Lifesciences Ltd	Equity	₹3.01 Cr	2.92%
Mankind Pharma Ltd	Equity	₹2.98 Cr	2.89%
Glenmark Pharmaceuticals Ltd	Equity	₹2.97 Cr	2.88%
Artemis Medicare Services Ltd Ordinary Shares	Equity	₹2.97 Cr	2.88%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹2.63 Cr	2.55%
Dr Agarwal’s Health Care Ltd	Equity	₹2.62 Cr	2.54%
Biocon Ltd	Equity	₹2.62 Cr	2.54%
OneSource Specialty Pharma Ltd	Equity	₹2.28 Cr	2.21%
Treps	Cash - Repurchase Agreement	₹1.63 Cr	1.58%
Syngene International Ltd	Equity	₹1 Cr	0.97%
Net Receivables / (Payables)	Cash	₹-0.1 Cr	0.10%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹95.75 Cr	92.87%
Basic Materials	₹5.83 Cr	5.65%

Risk & Performance Ratios

Fund Managers

Sudhanshu Asthana

Since April 2026

Dhaval Sangoi

Since September 2026

Additional Scheme Detailsas of 31st August 2026

ISIN

INF397L01LK4

Expense Ratio

1.42%

Exit Load

1.00%

Fund Size

₹103 Cr

Age

7 years 6 months

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Invesco India Pharma and Healthcare Fund Regular Growth Very High Risk	-	0.0%	-	-
Invesco India Pharma and Healthcare Fund Direct Growth Very High Risk	-	0.0%	-	-
DSP Nifty Healthcare ETF Very High Risk	0.3%	-	₹18.12 Cr	15.4%
Groww BSE Hospitals ETF Very High Risk	0.6%	-	₹158.55 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.3%	-	₹15.08 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	1.2%	0.0%	₹319.40 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹319.40 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	1.0%	1.0%	₹507.42 Cr	13.9%
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.5%	1.0%	₹507.42 Cr	12.0%
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.6%	1.0%	₹405.91 Cr	22.3%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹405.91 Cr	24.3%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹125.15 Cr	26.0%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹125.15 Cr	24.0%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹902.24 Cr	23.0%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹902.24 Cr	25.2%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
Kotak Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹767.70 Cr	30.1%
Kotak Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹767.70 Cr	28.1%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹3310.64 Cr	27.3%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹3310.64 Cr	28.7%
Nippon India Pharma Fund Direct Growth Very High Risk	1.0%	1.0%	₹9479.08 Cr	13.1%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	2.1%	1.0%	₹6995.62 Cr	8.0%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.3%	1.0%	₹6995.62 Cr	8.8%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹3835.28 Cr	17.2%
DSP Healthcare Fund Regular Growth Very High Risk	2.0%	0.0%	₹3835.28 Cr	15.7%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹103.11 Cr	18.1%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.7%	1.0%	₹103.11 Cr	16.5%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹428.30 Cr	20.3%
quant Healthcare Fund Regular Growth Very High Risk	3.1%	1.0%	₹428.30 Cr	18.3%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1443.57 Cr	18.9%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹5796.42 Cr	23.0%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	0.0%	₹1565.28 Cr	8.7%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹1565.28 Cr	10.3%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.1%	-	₹236.93 Cr	15.5%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	2.0%	0.0%	₹5796.42 Cr	21.8%
Nippon India Pharma Fund Regular Growth Very High Risk	1.8%	1.0%	₹9479.08 Cr	12.1%
UTI Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹1443.57 Cr	17.8%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹24.23 Cr	15.2%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1760.51 Cr	22.2%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.6%	1.0%	₹3555.18 Cr	20.4%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹3555.18 Cr	22.1%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹276.23 Cr	12.9%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹276.23 Cr	15.0%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹83.40 Cr	15.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1102.73 Cr	18.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹1102.73 Cr	19.6%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.4%	-	₹44.84 Cr	17.3%

About the AMC

LIC Mutual Fund

+91 022-66016000

https://www.licmf.com/

Total AUM

₹50,417 Cr

Address

4th Floor, Industrial Assurance Building, Mumbai, 400 020

Other Funds by LIC Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
LIC MF Technology Fund Direct Growth Very High Risk	1.1%	1.0%	₹95.03 Cr	-
LIC MF Consumption Fund Direct Growth Very High Risk	1.2%	1.0%	₹460.73 Cr	-
LIC MF Multi Asset Allocation Fund Regular Growth Very High Risk	1.1%	1.0%	₹1004.98 Cr	7.2%
LIC MF Manufacturing Fund Direct Growth Very High Risk	1.5%	1.0%	₹781.06 Cr	15.5%
LIC MF Large & Mid Cap Fund Direct Growth Very High Risk	1.7%	1.0%	₹3198.49 Cr	1.7%
LIC MF Aggressive Hybrid Fund Direct Growth Very High Risk	1.7%	1.0%	₹561.90 Cr	5.1%
LIC MF Medium to Long Duration Bond Fund Direct Growth Moderate Risk	0.2%	0.0%	₹174.85 Cr	4.9%
LIC MF Flexi Cap Fund Direct Growth Very High Risk	1.9%	1.0%	₹1125.39 Cr	5.4%
LIC MF Gilt Fund Direct Growth Moderate Risk	0.7%	0.0%	₹44.53 Cr	2.9%
LIC MF Banking & PSU Debt Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹1648.88 Cr	5.4%
LIC MF Large Cap Fund Direct Growth Very High Risk	1.4%	1.0%	₹1384.68 Cr	-4.6%
LIC MF Low Duration Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹2009.91 Cr	6.5%
LIC MF S & P Sensex Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹91.37 Cr	-8.4%
LIC MF Nifty 50 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹366.14 Cr	-6.4%
LIC MF Infrastructure Fund Direct Growth Very High Risk	1.4%	1.0%	₹1174.02 Cr	10.8%
LIC MF Liquid Plan Direct Growth Low to Moderate Risk	0.1%	0.0%	₹17484.09 Cr	6.5%
LIC MF ELSS Direct Growth Very High Risk	1.3%	0.0%	₹1021.43 Cr	-3.2%
LIC MF Gold ETF FOF Direct Growth High Risk	0.3%	1.0%	₹858.31 Cr	31.0%
LIC MF Equity Savings Fund Direct Growth Moderate Risk	1.9%	1.0%	₹38.78 Cr	3.3%
LIC MF Nifty Next 50 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹112.27 Cr	5.0%
LIC MF Short Duration Fund Direct Growth Low to Moderate Risk	0.4%	0.0%	₹124.04 Cr	5.6%
LIC MF Arbitrage Fund Direct Growth Low Risk	1.2%	0.0%	₹310.12 Cr	6.8%
LIC MF Balanced Advantage Fund Direct Growth Very High Risk	1.6%	1.0%	₹695.74 Cr	2.4%
LIC MF Focused 30 Equity Direct Growth Very High Risk	2.7%	1.0%	₹175.27 Cr	2.9%
LIC MF Long Term Value Fund Direct Growth Very High Risk	1.8%	1.0%	₹301.53 Cr	22.0%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹103.11 Cr	18.1%
LIC MF Small Cap Fund Direct Growth Very High Risk	1.3%	1.0%	₹831.55 Cr	15.9%
LIC MF Conservative Hybrid Fund Direct Growth Moderate Risk	1.7%	1.0%	₹46.86 Cr	3.9%
LIC MF Midcap Fund Direct Growth Very High Risk	1.8%	1.0%	₹392.12 Cr	7.3%
LIC MF Banking & Financial Services Fund Direct Growth Very High Risk	1.6%	1.0%	₹274.51 Cr	3.7%
LIC MF Money Market Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹4215.78 Cr	6.7%
LIC MF Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹732.25 Cr	5.3%
LIC MF Multi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹2253.92 Cr	9.3%
LIC MF Dividend Yield Fund Direct Growth Very High Risk	0.9%	1.0%	₹759.21 Cr	6.6%
LIC MF Ultra Short Duration Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹677.57 Cr	6.8%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of LIC MF Healthcare Fund Direct Growth?

The NAV of LIC MF Healthcare Fund Direct Growth, as of 23-Sep-2026, is ₹38.25.

What are the returns of LIC MF Healthcare Fund Direct Growth?

The fund has generated 18.09% over the last 1 year and 23.99% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of LIC MF Healthcare Fund Direct Growth?

The fund's allocation of assets is distributed as 98.52% in equities, 0.00% in bonds, and 1.48% in cash and cash equivalents.

Who manages the LIC MF Healthcare Fund Direct Growth?

The fund managers responsible for LIC MF Healthcare Fund Direct Growth are:-

Sudhanshu Asthana
Dhaval Sangoi

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

LIC MF Healthcare Fund Direct Growth

Fund Overview